঩মੌ௶သു৾ভ‫ؙ‬ਸ਼৚পভ‫ق‬পଚ‫ك‬উটॢছ঒ࠕ⣽⬊ࢆィ㸦ࡳ㸧ࡿࠖ༓㔛ࣛ࢖ࣇࢧ࢖࢚ࣥࢫࢭࣥࢱ࣮ ኱㜰ᗓ㇏୰ᕷ᪂༓㔛ᮾ⏫ ࠉࠉࠉࠉࠉ኱఍㛗㸸ྂỤ࣮ᴋ⏣⨾ಖࠉࠉࠉࠉࠉ㸦ᅜ❧◊✲㛤Ⓨἲே་⸆ᇶ┙࣭೺ᗣ࣭ᰤ㣴◊✲ᡤ㻝া঩ ਷ ঩৯ਭહ৫઩㛤఍ࡢ㎡ࠉᏛ఍㛗୰ᮧᖾኵ ⌮໬Ꮫ◊✲ᡤࣂ࢖࢜ࣜࢯ࣮ࢫࢭࣥࢱ࣮ࢩ࣏ࣥࢪ࣒࢘䚷䚷9:00 - 10:30

ౠশSP-1-1ࠕ⮫ᗋᛂ⏝ࢆ┠ᣦࡋࡓᇵᆅ⤌ᡂࡢ⪃࠼᪉࡜ࡑࡢရ㉁⟶⌮ࠖཌ⏕ປാ┬㠉᪂ⓗ་⸆ရ࣭་⒪ᶵჾ࣭෌⏕་⒪〇ရᐇ⏝໬ಁ㐍஦ᴗᡂᯝⓎ⾲༓㔛࣮࣒ࣝ$র੨ౘ୏ ৶৲৾ଢ଼஢ਚংॖड़জ९‫ش‬५७থॱ‫ ش‬ଜా೗ધ ਎੃প৾ગেୢఐ৾ଢ଼஢ਚ

Points to consider for the clinical applications of cultured cellsᇵ㣴⣽⬊ࡢ෌⏕་⒪฼⏝࡟࠾ࡅࡿ␃ពⅬଜా೗ધ਎੃প৾ગেୢఐ৾ଢ଼஢ਚᶦਙୌ಍ཝଢ଼஢ী৙
SP-1-2Feeder-free and xeno-free culture of human induced pluripotent stem cells
ࣄࢺL36⣽⬊ࡢࣇ࢕࣮ࢲ࣮ࣇ࣮ࣜ㸭ࢮࣀࣇ࣮ࣜᇵ㣴ທఘਦ঳୙ൈਉྒྷఱଽ௖ပি஖৳ౖਉਫଝੈਮ৅ᇪংॖड़ઙૄভ঺ૼ୒৫৅৖বয়ଢ଼஢৫৅১যୢఇ੦ೕ‫؞‬௏೨‫؞‬౭ുଢ଼஢ਚ঄ॺୌ಍ཝૢ৷৫৅஼ੈਮ৅ᇪय़জথઙૄভ঺ଢ଼஢৫৅ম৖
SP-1-3Facilitation of quality control of human pluripotent stem cells using
rBC2LCNࣄࢺከ⬟ᛶᖿ⣽⬊≉␗ⓗࣉ࣮ࣟࣈU%&/&1ࢆ⏝࠸ࡓရ㉁⟶⌮ᢏ⾡㛤Ⓨటઢဣᇩবয়ଢ଼஢৫৅১যਓ঵ૼ୒੕়ଢ଼஢ਚ൉ఇ੦ೕଢ଼஢৖୅೬ህ࣮࣡ࢡࢩࣙࢵࣉ䚷䚷10:40 - 12:16ౠশࠕ⣽⬊ቑṪ࣭ศ໬ࠖࠉ༓㔛࣮࣒ࣝ$ฒಘ࿪ ਎੃প৾L36಍ཝଢ଼஢ਚ ೔᫖෥৥ ஗঵ে੟ৱ౺ଢ଼஢ਚWS-1-1

Differentiation propensity of PSC cultured with StemFit®
6WHP)LWp$.࡛ᇵ㣴ࡉࢀࡓከ⬟ᛶᖿ⣽⬊ࡢศ໬≉ᛶૈমิื-HVVLFD&+$1*(Y\U\DQWL$*81*૸িల৵௔ୌ
௡भಞઙૄভ঺ॖঀঋ‫ش‬३ঙথଢ଼஢ਚ
WS-1-2

Novel culture system for pluripotent stem cell with bFGF-binding
recombinant proteinE)*)⤖ྜᛶࣜࢥࣥࣅࢼࣥࢺࢱࣥࣃࢡ㉁ࢆ⏝࠸ࡓࣄࢺL36⣽⬊ࡢ᪂つᇵ㣴ἲ㛤Ⓨ੨঱ ඥ୬ ໙৙ ௟঳ প৙ ૓๑ ༖ો ཟ୬ ৙ৄ৛ ଫ၈ ৐ਆ ส಻ ࿢ ཛྷ঳୙඾୲ஸஶ೦

୕૒ইॖঝ঒ઙૄভ঺5 'ଁฐম৖ગেୢ௜ଢ଼஢ਚবয়ਛ୘ୢ௜ଢ଼஢७থॱ‫ش‬㻞WS-1-3



Maintenance and expansion of human hematopoietic stem and progenitor
cells in the presence of defined factors alone.D]XKLUR 68'2 6DWRVKL <$06$=$., +LURPLWVX 1$.$8&+, DQG <XNLR
1$.$085$
&HOO(QJ'LY%LR5HVRXUFH&HQWHU5,.(1/DERI6WHP&HOO7KHUDS\&HQWHUIRU([S0HG7KH,QVWRI0HG6FLHQFH8QLYRI7RN\R
WS-1-4Regulation of PINK1 expression under oxidative stress conditions+LWRVKL085$7$+LWRVKL7$.$0$768.HQLFKL<$0$02725LH
.,126+,7$.HQ.$7$2.$1DPKR+8+DQG0DVDNL\R6$.$*8&+,
'HSDUWPHQWRI&HOO%LRORJ\2ND\DPD8QLYHUVLW\*UDGXDWH6FKRRORI

0HGLFLQH'HQWLVWU\DQG3KDUPDFHXWLFDO6FLHQFHV'HSDUWPHQWRI/LIH
6FLHQFH)DFXOW\RI6FLHQFH2ND\DPD8QLYHUVLW\RI6FLHQFH
WS-1-5

Technical know-how in human hepatocyte isolation and preservation

6KLQ(126$:$'LYLVLRQ IRU $GYDQFHG 0HGLFDO 6FLHQFHV 1DWLRQDO &HQWHU IRU &KLOG +HDOWKDQG'HYHORSPHQW
WS-1-6



Development of functional hepatocyte culture system using new chimeraprotein

᪂つ࣓࢟ࣛࢱࣥࣃࢡ㉁ࢆ⏝࠸ࡓ⫢⣽⬊ࡢᶵ⬟ࢆྥୖࡉࡏࡿᇵ㣴ࢩࢫࢸ࣒ࡢ㛤Ⓨદઠ༟ଐਧিથ౶

বয়ଢ଼஢৫৅১য੟ସ‫؞‬౫મଢ଼஢ਃଡে৬ਃચ౫મঘॽॵॺଫഏিপ৾৶ੵ

৾୒੹ॼঀ৶ੵ
WS-1-7

Development of a novel culture system for extrapolating the excretion ofhepatic metabolites into bile duct⫢௦ㅰ≀ࡢ⫹⟶ෆ᤼ἥࢆእᤄࡍࡿ᪂ࡋ࠸ᇵ㣴ࢩࢫࢸ࣒ࡢ㛤Ⓨ౒্న೔᫖෥৥
বয়ଢ଼஢৫৅১য஗঵ে੟ৱ౺ଢ଼஢ਚ৿੟ఐ৾ଢ଼஢୩ୠ
WS-1-8



Stk25-LKB1 signal has possible roles in neuronal development and function.
⚄⤒ᴟᛶไᚚ࡟㛵ࢃࡿ6WN/.%ࢩࢢࢼࣝࡀ⚄⤒⣔ࡢⓎ㐩࡜ᶵ⬟࡟ᯝࡓࡍᙺ๭ૈ਽ᆑනஏ৥ের৛ྯ௟ఎੴ਩ੱମ௽૩঻॥টॽ‫ش‬৅୸௽૩ଢ଼஢ਚ৅ে௽૩৾৖㻟ࢹ࢕࣮ࣉࢹ࢕ࢫ࢝ࢵࢩࣙࣥ䚷䚷9:30 - 11:55
ࠕ⭘⒆㸯ࠖࠉࠉ5RRPౠশ
DD-1

5HQX:$'+:$ ਓ঵ૼ୒੕়ଢ଼஢ਚ ൺળ௏ ળ৛৶ఐপ৾


Anticancer and anti-stress activities in Ashwagandha Leaves: endorsementfrom cell culture assays

6XQLO.$8/5HQX:$'+:$'$,/$% 1DWLRQDO ,QVWLWXWH RI $GYDQFHG ,QGXVWULDO 6FLHQFH

7HFKQRORJ\$,67DD-2

  Extract of Cordyceps militaries inhibits angiogenesis and suppresses tumor
growth of human malignant melanoma cells෤⹸ኟⲡᢳฟ⁐ᾮ࡟ࡼࡿᝏᛶ࣓ࣛࣀ࣮࣐⣽⬊ࡢቑṪ࡜⾑⟶᪂⏕ࡢᢚไॖঐॹक़ॕॼঝ१ঝঐग़থॹॕक़ॕॲখউॺছথॺ੺ઢஶ੿੩঱མஂ৛ম௏঳੨িಉଚઠ৆஬ળ৛প৾ୢຓఇ৾੕়ଢ଼஢ఐ ৗඎপ৾প৾੹ୢຓ৾੕়ଢ଼஢ఐ ණ஝প৾প৾੹ੵ৾ଢ଼஢ఐ
DD-3Mortalin regulates epithelial-mesenchymal transition and cancer metastasis.

5HQX:$'+:$6XQLO.$8/'%7$,67 ,QWHUQDWLRQDO /DERUDWRU\ IRU $GYDQFHG %LRPHGLFLQH '$,/$% 
1DWLRQDO,QVWLWXWHRI$GYDQFHG,QGXVWULDO6FLHQFH 7HFKQRORJ\ $,67೬ህࠕ⭘⒆㸰࣭⣽⬊Ṛࠖࠉࠉ5RRPౠশઢ੩ਐ౶৕ ઁਣপ৾ ਽உਉቮൌ ઁਣপ৾DD-47*)ǃV\QHUJL]HVZLWKGHIHFWVLQWKH+LSSRSDWKZD\LQPDOLJQDQWmesothelioma growthᝏᛶ୰⓶⭘ࡢቑṪ࡟࠾ࡅࡿ7*)ș࡜+LSSRSDWKZD\ࡢ༠ㄪⓗᙺ๭ઢ੩ਐ౶৕ઁਣপ৾প৾੹ୢຓఇ৳௏৾ଢ଼஢੹‫ؙ‬ব੠ຓఐୢ৾৴௚৫৅৾ଢ଼஢஼

DD-5  Inhibition of cancer cell growth by senescence-inducible miRNA⪁໬ㄏᑟPL51$࡟ࡼࡿࡀࢇ⣽⬊ࡢቑṪᢚไ਽உਉቮൌ৛মሬ౴ৈ਽ᵷ୬ധমႀিਉ౭෥ઁਣপ৾প৾੹ୢຓఇ৳௏৾ଢ଼஢੹‫ؙ‬಍ཝী৕ে੟৾ଢ଼஢஼

DD-6



CARF activates p53 and represses p21 to cause two-way control on cellproliferation

5DMNXPDU6.$/5$6XQLO&.$8/DQG5HQX:$'+:$'$,/$%1DWLRQDO,QVWLWXWHRI$GYDQFHG,QGXVWULDO6FLHQFH 7HFKQRORJ\
DD-7



Sarcoma cell lines: Current status and perspectives;LDRTLQJ3$1$NLKLNR<26+,'$$NLUD.$:$,7DGDVKL.21'2
'LY RI 5DUH &DQFHU 5HV 1DWO &DQFHU &WU 5HV ,QVW 'HSW RI 3DWKRO

1DWO &DQFHU &WU +RVS 'HSW 0XVFXORVNHOWDO 2QFRO 1DWO &DQFHU &WU
+RVS

㻠

DD-8

  Loss of anchorage primarily induced non-apoptotic cell death in humanmammary epithelial cells under focal adhesion kinase signaling᥋╔႙ኻ࡟ࡼࡾங⭢ୖ⓶⣽⬊࡟ㄏᑟࡉࢀࡿ⣽⬊Ṛ࡟ࡘ࠸࡚㸹)$.ࢩࢢࢼࣝ࡟ࡼࡿ
㠀࢔࣏ࢺ࣮ࢩࢫ⣽⬊Ṛࡢไᚚ஌঳೦લਆધ೗ແඖସ৕
ೣਮপ৾ఇ৾৖ে৬ী৕ఇ৾൥ౠᇯᯂ಍ཝে੟৾৖୅

DD-9

Adenoviral gene therapy with suppressor of cytokine signaling (SOCS) forcancerࢧ࢖ࢺ࢝࢖ࣥࢩࢢࢼࣝఏ㐩ᢚไศᏊ 62&6 ࢆ⏝࠸ࡓ⒴࡟ᑐࡍࡿ᪂つ㑇ఏᏊ἞⒪ἲࡢ㛤Ⓨ਼ଐিცઢমᎈൎາ੘বয়ଢ଼஢৫৅১যୢఇ੦ೕ‫؞‬௏೨‫؞‬౭ുଢ଼஢ਚඊႵ३ॢॼঝউট४ख़ॡॺ(QJOLVKSUHVHQWDWLRQDZDUGV䚷㸦(3$ 䚷12:20 - 12:48ౠশ༓㔛࣮࣒ࣝ$৛মઉ౴ ઢি৳௏ୋেপ৾ ૈ਽ᆑ ఎੴ਩ੱମ௽૩঻॥টॽ‫ش‬৅୸௽૩ଢ଼஢ਚEPA-1

2SWLPL]DWLRQRISUHFLVHJHQRPHHGLWLQJLQKXPDQLQGXFHGSOXULSRWHQWVWHP.LPLKLNR %$112 <DVXML .,7$%$7$.( 6D\DND 2025, .DWVX\D +,5$7$
.HLLFKL2=212'HSDUWPHQWRI3HGLDWULFV*UDGXDWH6FKRRORI0HGLFLQH2VDND8QLYHUVLW\EPA-2

Loss-of-function screening for regulators of melanogenesis: identification ofrole of mortalin in pigmentation/LQJ/,1REXKLUR$1'2&KULVWLDQ0$+(6XQLO&.$8/DQG5HQX
:$'+:$'$,/$% $,67 7VXNXED 8QLYHUVLW\ RI 7VXNXED .. &KDQHO 5HVHDUFK

7HFKQRORJ\'HYHORSPHQW/DEছথॳॱॖ঒

⣽⬊ᇵ㣴ᣦᑟኈㅮ⩦఍䚷䚷13:30 - 14:30
༓㔛࣮࣒ࣝ$ౠশൺળ௏ ળ৛৶ఐপ৾ ઢ੩ਐ౶৕ ઁਣপ৾TS

Program for cell culturists and the instructors for cell culturing RUJDQL]HG by
the JTCA education & research committee᪥ᮏ⤌⧊ᇵ㣴Ꮫ఍ᩍ⫱◊✲ࢩࢫࢸ࣒ጤဨ఍୺ദb⣽⬊ᇵ㣴ᣦᑟኈㅮ⩦఍ൺળ ௏ ଽ௖ٕပি ஖৳ ઢ੩ ਐ౶৕ ঱ি ෑྒྷ ൝਽ ჵ಻ ฒಘ ࿪ র੨ ਮೣ௖ઢ࿙৕ਧᦑႎ঩মੌ௶သു৾ভઇ୘ଢ଼஢३५ॸ঒੻৩ভ㻡ࢩ࣏ࣥࢪ࣒࢘䚷䚷14:45 - 16:00
ࠉࠉࠉࠉࠉࠉࠉࠉࠉࠉࠉࠉࠉࠕL36⣽⬊ࡢရ㉁ኚື࡜ᐇ⏝໬ࢆ┠ᣦࡋࡓᇵ㣴ᢏ⾡ࡢᶆ‽໬ࠖ$0('෌⏕་⒪ᐇ⏝໬◊✲஦ᴗᡂᯝⓎ⾲༓㔛࣮࣒ࣝ$ౠশপඖ஬ শળૼ୒ఐ৾প৾ ඔਕྒྷ ୢఇ੦ೕ‫؞‬௏೨‫؞‬౭ുଢ଼஢ਚ
SP-2-1&KDUDFWHUL]DWLRQDQGGLIIHUHQWLDWLRQDELOLWLHVRIKXPDQL36FHOOFORQHV
established with different methodsᶞ❧᪉ἲࡢ㐪࠸࡟ࡼࡿࣄࢺL36⣽⬊ࡢရ㉁࡜ศ໬࡬ࡢᙳ㡪๹૊ྊ৛ਆາে୲৳഻৕পৈઌఱ஖রਧઌযਓ঵ૼ୒੕়ଢ଼஢ਚ‫ؙ‬൉ఇ੦ೕଢ଼஢৖୅໒ణপ৾প৾੹ে୵୭୆ఐ৾ଢ଼஢ఐ

SP-2-2



7KHHIIHFWVRIHQ]\PDWLFGLJHVWLRQRQSDVVDJHRIKXPDQSOXULSRWHQWVWHPFHOOVࣄࢺከ⬟ᛶᖿ⣽⬊ࡢ⥅௦సᴗ࡟࠾ࡅࡿ㓝⣲ฎ⌮ࡢᙳ㡪পඖ஬শળૼ୒ఐ৾প৾

SP-2-3

0HVRGHUPDOGLIIHUHQWLDWLRQDQGVWDQGDUGL]DWLRQLQKXPDQL36FHOOV୰⬇ⴥศ໬ㄏᑟἲࡢ㛤Ⓨ࡜ᶆ‽໬ਆഈ‫ؙ‬௏੸বয়ଢ଼஢৫৅১যୢఇ੦ೕ‫؞‬௏೨‫؞‬౭ുଢ଼஢ਚ‫ؙ‬ୌ಍ཝ਑౪উট४ख़ॡॺ೬ህ≉ูㅮ₇䚷䚷16:10 - 17:00
༓㔛࣮࣒ࣝ$ౠশଽ௖ပি஖৳ ୢఇ੦ೕ‫؞‬௏೨‫؞‬౭ുଢ଼஢ਚ

SL

Programs underlying mammalian brain development: lessons from live
imaging of brain slices့ங㢮኱⬻Ⓨ⏕ࡢ⚄⤒ᖿ⣽⬊ࣉࣟࢢ࣒ࣛ㸸OLYHLPDJLQJ࠿ࡽุࡿࡇ࡜
ૈ૊ધ௟৶৲৾ଢ଼஢ਚ੗಍ཝ३५ॸ঒஄ਛଢ଼஢७থॱ‫ش‬೬ህ㻢ዡບ㈹ᑐ㇟₇㢟䚷䚷17:15 - 17:43
༓㔛$%࢚ࣥࢺࣛࣥࢫ
ౠশ฻৙૕ಇ বয়ਛ୘ୢ௜ଢ଼஢७থॱ‫ش‬ଢ଼஢ਚ

YIA-1



Platelet-derived growth factor (PDGF)-AA/AB in human serum are potential
indicators of the proliferative capacity of human synovial mesenchymal stem⁥⭷ᖿ⣽⬊ࡢቑṪᛶࢆண ࡍࡿ⮬ᕫ⾑Ύホ౯ἲࡢ㛤Ⓨ਷৙௥ൺ৙༌৕পঢ়ਦ૱৵஌ཟ঳୙৵ি⁖ข੸ঢ়൰঳୙ূ਎ୢఐຓఐপ৾ગেୢ௜ଢ଼஢७থॱ‫ش‬
YIA-2



Establishment of efficient protocol for neural differentiation of humaninduced pluripotent stem cells and analysis of disease mechanisms in trisomyࣄࢺேᕤከ⬟ᛶᖿ⣽⬊࠿ࡽ⚄⤒⣽⬊ࡢຠ⋡ⓗ࡞ศ໬ㄏᑟἲࡢ☜❧࡜ࣄࢺࢺࣜࢯ
࣑࣮ᝈ⪅࡟࠾ࡅࡿ⚄⤒Ⓨ⏕㞀ᐖࡢ⑓ែゎ᫂਴ি๞໲௳৙ਁ಻প஌ଫืྒྷຏణಇสরਆಒఛ▏຋૓஖ਨ࿢೨ఘ
পଚপ৾প৾੹ୢ৾௺ଢ଼஢ఐ৵ుఐ৾
࣏ࢫࢱ࣮ࢭࢵࢩࣙࣥ䚷䚷17:45 - 18:34
༓㔛$%࢚ࣥࢺࣛࣥࢫ
ౠশૣিඤ౓ ୢఇ੦ೕ‫؞‬௏೨‫؞‬౭ുଢ଼஢ਚ

P-1



Development of novel medium for culturing naïve iPS cells

0LWVXUX,1$085$6KXQVXNH<26+,'$1DRNL1,6+,6+,7$



5HSUR&(//,QF1DWLRQDO,QVWLWXWHRI%LRPHGLFDO,QQRYDWLRQ

P-2



Development of measurement method for bioactivity in culture of humaninduced pluripotent stem cells

ࣄࢺL36⣽⬊ࡢᇵ㣴࡟࠾ࡅࡿቑṪᅉᏊࡢ⏕⌮άᛶᐃἲࡢ㛤Ⓨૣিඤ౓ ඔ‫ؙ‬ਕྒྷ ᆘ‫ؙ‬થઍ ਴੩෎৕ ଜా೗ધଽ௖ပি஖৳বয়ଢ଼஢৫৅১য ୢఇ੦ೕ‫؞‬௏೨‫؞‬౭ുଢ଼஢ਚ ঄ॺୌ಍ཝૢ৷৫৅஼ ਎੃প৾ગেୢఐ৾ଢ଼஢ਚୌ಍ཝଢ଼஢৖୅ᶦਙୌ಍ཝଢ଼஢ী৙
P-3



Development of a new cell-based-assay using human ES/iPS cell-derived
neural stem cells for developmental neurotoxicity testing

0LND68*$+LURDNL.,,7DND\XNL82=80,<DVXMLUR.,<27$DQG0LKR.)858(/DERUDWRU\ RI 6WHP &HOO &XOWXUHV 1DWLRQDO ,QVWLWXWHV RI %LRPHGLFDO,QQRYDWLRQ+HDOWKDQG1XWULWLRQ1LNRQ&RUSRUDWLRQP-4

,PDJHEDVHGL36FRORQ\PRUSKRORJ\DQDO\VLVIRUFXOWXUHSURWRFRORSWLPL]DWLRQ
L36⣽⬊ࢥࣟࢽ࣮ࡢ⏬ീ᝟ሗゎᯒࢆ⏝࠸ࡓᇵ㣴ᡭᢏࡢᐃ㔞ホ౯শ௳৶Ꮆ৕ሻ௖ኢ஬িຶઃ୙ଽ௖ပি஖৳ম੗ඥ౓ਸઢໄఘ

੡প੹൉ఇ‫؜‬੡প੹ੵ৾ઙૄভ঺ॽ॥থୢఇ੦ೕ‫؞‬௏೨‫؞‬౭ുଢ଼஢ਚ

㻣

P-5



Automatic cell selection system using cell morphology under gel cultureḟඖࢤࣝᇵ㣴࠿ࡽࡢᙧែ᝟ሗࢆ⏝࠸ࡓ⣽⬊ሢ⮬ື㑅ู⿦⨨ࡢ㛤Ⓨ෡িઌ੥ଯ‫ر‬਽བযি੨༿ຟሻ௖ኢૈ੩ඥఴൈ૕ઌဘപఓඦ੘স஌สౘਸઢໄఘ੡প੹൉ఇ ੡প੹ੵ৾ ਓ঵ૼ୒੕়ଢ଼஢ਚ ໒ణপୢ৾ ग़থ४ॽ॔জথॢ३५ॸ঒ઙૄভ঺
P-6



Effect of Y-27632 concentration on EB formation and differentiation intocardiomyocytes from human iPS cells52&.LQKLELWRU < ࡀࣄࢺL36⣽⬊ࡢ⬇ᵝయᙧᡂ࠾ࡼࡧᚰ➽ศ໬࡟ཬࡰࡍᙳ㡪੺ઢิਲপฮಜᄶహ᫖ག৛๤প‫؞੹؞‬ୢੵ੕়৛๤প‫؞‬ে୵୭୆‫؞‬ে୵ੵ

P-7Neural differentiation derived from mouse ES cells on chemical treated feeder໬Ꮫࣇ࢕࣮ࢲ࣮ୖ࡟࠾ࡅࡿ࣐࢘ࢫ(6⣽⬊ࡢ⚄⤒⣔⤌⧊࡬ࡢศ໬ㄏᑟ❅ଶਮ෎௣੩஖৳িਆ഻঳ূ਎ੵ঵প৾প৾੹ে୵৶ੵ৾ଢ଼஢ఐ
࣏ࢫࢱ࣮ࢭࢵࢩࣙࣥ䚷䚷17:45 - 18:34
༓㔛$%࢚ࣥࢺࣛࣥࢫ
ౠশ৵ਉથ൞ ୢఇ੦ೕ‫؞‬௏೨‫؞‬౭ുଢ଼஢ਚ

P-8



The effects of neuregulin 1 or fibroblast growth factor 1 on the celldifferentiation of mouse embryonic submandibular gland ex vivo culture࣐࢘ࢫ⫾ඣ㢡ୗ⭢ୖ⓶⤌⧊ࡢయእᇵ㣴࡟࠾ࡅࡿQHXUHJXOLQ࡜ILEUREODVWJURZWKIDFWRUࡢ⣽⬊ศ໬࡬ࡢస⏝ঢ়ጣ৥৕ଫ௳ົয৙ਆ๒ౘঢ়ጣਫౘ৛஄প৾‫؞‬ୢ‫่؞‬૧૸୴প৾‫੹؞‬৶ૣਣ਩য়ୢఐপ‫؞‬ୢP-9

The establishment of banking system for bioresources derived from surplus
tissues of hyperdactylia in human tissue bankከᣦ ㊑ ⑕ࡢᙧᡂእ⛉ᡭ⾡࡟࠾࠸࡚᦬ฟࡉࢀࡿవ๫⤌⧊ࡢ◊✲㈨※໬ཬࡧศㆡപਉ ஦৵ଚ ิ੬ ଯઢ ੪ਦ পਧ ຀ ୺ি ূన ৵ਉ થ൞ ฻৙૕ ಇૈ৛ྊધୢఇ੦ೕ‫؞‬௏೨‫؞‬౭ുଢ଼஢ਚ‫؞‬൉ఇৱ౺৖বয়ਛ୘ୢ௜ଢ଼஢७থॱ‫ش‬

P-10



Beta3 integrin cDNA-transduced human keratinocytes grow far better onfibrin gels as compared to normal human keratinocytes%HWD࢖ࣥࢸࢢࣜࣥF'1$ᑟධࣄࢺࢣࣛࢳࣀࢧ࢖ࢺࡣṇᖖࣄࢺࢣࣛࢳࣀࢧ࢖ࢺ࡟ẚ࡭࡚ࣇ࢕ࣈࣜࣥࢤࣝୖ࡛⣽⬊ቑṪࡀቑຍࡍࡿ
୲৳஖৻৕ଚઠ৆஬
ળ৛প৾প৾੹ୢຓఇ৾੕়ଢ଼஢ఐ಍ཝে੟৾ী৙

㻤

P-11



Inactivation of adenovirus infecting human pharyngeal cancer cells bydisinfectant Etakࣄࢺဗ㢌⒴⣽⬊࡟ឤᰁࡉࡏࡓ࢔ࢹࣀ࢘࢖ࣝࢫ࡟ᑐࡋ࡚ᢠ⳦๣(WDNࡀཬࡰࡍ୙ά໬స⏝ઢিཟஂ‫؜‬ਕ੨ෞ৻‫؜‬੣ઢჵඥ‫؜‬਽ਉማื‫؜‬ఖਉਮ৕‫؜‬ি৉ൻ‫੸؜‬ਆข౴ઁਣপ৾প৾੹ୢຓఇ৳௏৾ଢ଼஢੹ଁ়௏೨ఐ৾৖୅ઠᒷে੟ੵ৾ী৙P-12



Increased expressions of Wnt5a in osteoblast by titanium ion andlipopolysaccharide and its involvement in osteoclast differentiationࢳࢱࣥ࢖࢜ࣥ࠾ࡼࡧ/36࡟ࡼࡿ㦵ⱆ⣽⬊ࡢ:QWDⓎ⌧ࡢୖ᪼࡜◚㦵⣽⬊ศ໬࡬ࡢ㛵୚৘ਆၔৈ਽ေ୬୙੣ઢჵඥਕ੨ෞ৻ি৉ൻఖਉਮ৕੸ਆข౴
ઁਣপ৾প৾੹ୢຓఇ৳௏৾ଢ଼஢੹ଁ়௏೨ఐ৾৖୅ઠᒷে੟ੵ৾ী৙
P-13



Karyotypic analysis of human ES/iPS cells serially cultured in laboratory
ࣄࢺ(6L36⣽⬊ࡢᇵ㣴⥔ᣢ࡟࠾ࡅࡿᰁⰍయ᳨ᰝࡢ㔜せᛶ଄௔ઌ৶঱িઉ৕ඔਕྒྷଽ௖ပি஖৳
বয়ଢ଼஢৫৅১যୢఇ੦ೕ‫؞‬௏೨‫؞‬౭ുଢ଼஢ਚ঄ॺୌ಍ཝૢ৷৫৅஼
P-14



Array analysis of single-cell copy number variations࣐࢖ࢡࣟ࢔ࣞ࢖ࢆ⏝࠸ࡓ⣽⬊࠿ࡽࡢࢤࣀ࣒ࢥࣆ࣮ᩘ␗ᖖࡢ᳨ฟৈিऴा඾୲ஸஶ೦టূ౶৕৓ৃ࿜

⌆‫ॵॳڶۃڹ‬উଢ଼஢ਚবয়ଢ଼஢৫৅১যবয়ਛ୘ୢ௜ଢ଼஢७থॱ‫ش‬ଢ଼஢ਚ༦஡ভ૸౔ছॖই१ॖग़থ५७থॱ‫ڲش‬మ૸౔ঝ‫ش‬঒%㻥া঩ ਽ ঩৯࣮࣡ࢡࢩࣙࢵࣉ䚷9:00 - 10:40ࠕᇵ㣴⣽⬊ࢆ⏝࠸ࡓࢫࢡ࣮ࣜࢽࣥࢢ⣔ࡢᵓ⠏࡜ẘᛶホ౯ࠖࠉࠉࠉ༓㔛࣮࣒ࣝ$ౠশর੨ਮೣ বয়ਛ୘ୢ௜ଢ଼஢७থॱ‫ش‬ଢ଼஢ਚ ৵ਣᇣ বয়ୢఇષ୫ષୋেଢ଼஢ਚWS-2-1Body on a Chip: Towards in vitro recapitulation of the side effects of anticancer drugsᢠࡀࢇ๣๪స⏝ࢆ෌⌧ࡍࡿ⏕యእࣔࢹࣝ%RG\RQD&KLSࡢ㛤Ⓨน੩ေ঳୙‫؜‬਴੩ଝਮ‫؜‬ਸઢଝ੦‫؜‬ଅોඈ૓‫؜‬িഒఊ਎੃প৾੟ସ಍ཝଁ়३५ॸ঒ುਡ‫؜‬਎੃প৾প৾੹ੵ৾ଢ଼஢ఐ

WS-2-2

,PSURYHPHQWRIWKHHPEU\RWR[LFLW\WHVWE\(6FHOOV8WLOL]DWLRQRIWKH
metabolic activation factor using liver-derived cells(6⣽⬊࡟ࡼࡿⓎ⏕ẘᛶホ౯⣔ࡢᨵⰋࠉ㸫⫢⏤᮶⣽⬊ࢆ⏝࠸ࡓ௦ㅰάᛶᅉᏊᑟධ
০੩൞঳পଚຓఐপ৾ຓఐ৶ੵ৾൥ౠ

WS-2-3

Development of high functional hepatocyte culture system and toxicityevaluation system㧗ᶵ⬟⫢⣽⬊ᇵ㣴⣔ࡢ᳨ウ࡜ẘᛶホ౯⣔㛤Ⓨࡢヨࡳর੨ਮೣবয়ਛ୘ୢ௜ଢ଼஢७থॱ‫ش‬ଢ଼஢ਚఇද੘௜ଢ଼஢৖ৰୡఇ৶ଢ଼஢஼
WS-2-4Generation of functional hepatocytes from human pluripotent stem cells forpharmaceutical studies

ࣄࢺL36⣽⬊⏤᮶ศ໬ㄏᑟ⫢⣽⬊ࡢస〇࡜๰⸆◊✲࡬ࡢᛂ⏝਷ઠඥ౓পଚপ৾প৾੹ఇ৾ଢ଼஢ఐপଚপ৾প৾੹ୢ৾௺ଢ଼஢ఐপଚপ৾ব੠ୢੵੲਾ७থॱ‫ش‬বয়ଢ଼஢৫৅১যୢఇ੦ೕ‫؞‬௏೨‫؞‬౭ുଢ଼஢ਚ
WS-2-5

In vitro WHVWPHWKRGVDFFHSWHGE\,QWHUQDWLRQDORUJDQL]DWLRQᅜ㝿ᶵ㛵࡛ᢎㄆࡉࢀ࡚࠸ࡿLQYLWUR ヨ㦂ἲ৵ਣᇣবয়ୢఇષ୫ષୋেଢ଼஢ਚ



೬ህ

࣮࣡ࢡࢩࣙࢵࣉ䚷10:50 - 11:58
ࠉࠕศ໬⣽⬊ࠖࠉࠉ༓㔛࣮࣒ࣝ$ౠশ੸ਆข౴ ઁਣপ৾ ࿞੩௏୏ ঩মຓఐপ৾WS-3-1



miR-125b plays a crucial role in osteoblast-osteoclast communication
PL5E࡟ࡼࡿ㦵ⱆ⣽⬊࡜◚㦵⣽⬊ࡢ⣽⬊㛫ࢥ࣑ࣗࢽࢣ࣮ࢩࣙࣥ୺৕ඥ੸ઁਣপ৾প৾੹ୢຓఇ৳௏৾ଢ଼஢੹ຓ৾ী৙ໂੌ௶৻පে੟৾

㻝㻜

WS-3-2

Ability to form a dentin/pulp-like complex of CD146 positive human dentalpulp stem cells&'㝧ᛶࣄࢺṑ㧊ᖿ⣽⬊ࡢ㇟∳㉁ṑ㧊ᵝ」ྜయᙧᡂ⬟ૈ੩஖౶৕৵௔ა৕࿞੩௏୏঩মຓఐপ৾ে୵ຓ৾৖ఇ৶৾൥ౠ
WS-3-3Generation and transplantation of 3D organ buds from mouse skin tissue⓶⭵⤌⧊ཎᇶࡢᇵ㣴ෆస〇࡜ࡑࡢ⛣᳜ৡ૱མ੘ๅি୬຤ဢ৖௟੦▏ாೢઃൺળ௏ળ৛৶ఐপ৾প৾੹৶৾ଢ଼஢ఐಏ෫ে୵ఐ৾௧వ಍ཝে੟৾ଢ଼஢஼ળ৛৶ఐপ৾প৾੹৶৾ଢ଼஢ఐಏ෫ে୵ఐ৾௧ੌ௶୰ଙ৾ଢ଼஢஼
WS-3-4



'LIIHUHQWLDWLRQRI+89(&FXOWXUHGRQVHOIDVVHPEOLQJSHSWLGHJHO⮬ᕫ㞟ྜᛶ࣌ࣉࢳࢻࢤ࡛ࣝᇵ㣴ࡋࡓࣄࢺ⮖ᖏ㟼⬦ෆ⓶⣽⬊ࡢศ໬০਍ਫ౴ৈ௿൞ᄶઙૄভ঺ওॽ॥থ੕়ଢ଼஢ਚ੡ଽો৘য়প৾প৾੹ୢ৾ଢ଼஢ఐુ৊ଢ଼஢ઇ୘

७থॱ‫ش‬WS-3-5



Application of the three-dimensional cornea model using the human
LPPRUWDOL]DWLRQFRUQHDOHSLWKHOLXPࣄࢺ୙Ṛ໬ゅ⭷ୖ⓶⣽⬊ࢆ⏝࠸ࡓ୕ḟඖゅ⭷ࣔࢹࣝࡢ᭷⏝ᛶ৛ম ઉ౴ ਴ૈ ෇৕ ਸઢ ଝઉ ଯઢ ࿖ রি ༔ ૈ੩ ર৕ ઌ৙ ഻ஂਉਮ๒ੜẍ෌౶৕র੨৆ಂ৵ਣᇣઢি৳௏ୋেপ৾ુ৊ਹ৷ଢ଼஢઱ਝী৕ে੟৾঩মওॼ‫ॻش‬৲ဲષઙૄভ঺঍‫ش‬ঘ‫ش‬ઙૄভ঺বয়ୢఇષ୫ષୋেଢ଼஢ਚఇ৶৖ৗૠ૥ୡ১௬੼஼

ছথॳॱॖ঒⥲఍䚷䚷13:00-14:00
༓㔛࣮࣒ࣝ$
ᖿ஦఍ሗ࿌䚸Ỵ⟬ሗ࿌䚸᮶ᖺᗘண⟬䚸ዡບ㈹䛚䜘䜃㻱㻼㻭ཷ㈹⪅Ⓨ⾲㻌➼㻝㻝ࢩ࣏ࣥࢪ࣒࢘䚷䚷14:45 - 16:00
ౠশࠕᇵ㣴⣽⬊ࡢᙧែࢆホ౯ࡍࡿࠖࠉ༓㔛࣮࣒ࣝ$౶ঀળਫ೗ পଚপ৾ ਸઢໄఘ ੡ଽોপ৾SP-3-1

The influence of cell morphological change on extent of maturation as well as
direction of differentiation in cultureᇵ㣴୰ࡢ⣽⬊ᙧែኚ໬ࡢศ໬ᡂ⇍ᗘ࠾ࡼࡧศ໬ᣦྥᛶ࡟ᑐࡍࡿᙳ㡪౶ঀળਫ೗
পଚপ৾প৾੹ੵ৾ଢ଼஢ఐ
SP-3-2



Cell tracking technology for evaluation of cell condition⣽⬊ホ౯ࡢࡓࡵࡢ⣽⬊ࢺࣛࢵ࢟ࣥࢢᢏ⾡ଯణအপ঩মഀླྀઙૄভ঺
SP-3-3

Live cell imaging analysis with confocal image cytometerඹ↔Ⅼ࢖࣓࣮ࢪࢧ࢖ࢺ࣓࣮ࢱ࣮࡟ࡼࡿᇵ㣴⣽⬊ࡢホ౯ᄱ਽৾৛૝ઁ౓
૯ఖਗ਼ਃ ઙ ੑ೾হ঵ম৖ছॖই१ॖग़থ५७থॱ‫ش‬SP-3-4

೬ህ

Image-based informatic analysis for label-free evaluation of cell culture㢧ᚤ㙾⏬ീࢆ⏝࠸ࡓ⣽⬊ᙧែ᝟ሗゎᯒ࡟ࡼࡿ㠀◚ቯホ౯ਸઢໄఘ੡ଽોপ৾൉ఇఐ৾ଢ଼஢ఐ
SP-3-5

Image Analysis for Cultivated Cellsᇵ㣴⣽⬊ࡢ⏬ീゎᯒἲ࡟ࡘ࠸࡚ᇬ੩ඤఴૈਉැ୬ૈমྌ৛ઠ೗ఘ඾୲ஸஶ೦୕૒ইॖঝ঒ઙૄভ঺઺൸ૼ୒७থॱ‫ش‬বয়ਛ୘ୢ௜ଢ଼஢७থॱ‫ش‬ଢ଼஢ਚে༢‫؞‬಍ཝୢ௜ଢ଼஢৖
SP-3-6

$SSOLFDWLRQIRUQRQLQYDVLYHFHOOFXOWXUHFKDUDFWHUL]LQJPHWKRGXVLQJOLYHFHOO
imagingࣄࢺከ⬟ᛶᖿ⣽⬊ࡢᙧែ⏬ീࢆ⏝࠸ࡓᇵ㣴ᕤ⛬⟶⌮ᢏ⾡࡜ࡑࡢᛂ⏝஬িຶઃ୙ઙૄভ঺ॽ॥থ

SP-3-7

Development and application of morphological evaluation for humanpluripotent stem cellsࣄࢺከ⬟ᛶᖿ⣽⬊ࡢᙧែホ౯ᐃἲ㛤Ⓨ࡜ࡑࡢ฼⏝ଽ௖ٕပি஖৳বয়ଢ଼஢৫৅১যୢఇ੦ೕ‫؞‬௏೨‫؞‬౭ുଢ଼஢ਚ঄ॺୌ಍ཝૢ৷৫৅஼㛢఍ࡢ㎡኱఍㛗ࠉྂỤ㸫ᴋ⏣⨾ಖ㻔ᅜ❧◊✲㛤Ⓨἲே㻌་⸆ᇶ┙䞉೺ᗣ䞉ᰤ㣴◊✲ᡤ㻕㻝㻞